UBS Group’s Autonomix Medical AMIX Stock Holding History

UBS Group’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,595	Closed	-$13.1K	–	11134
2026 Q1	$13.1K	Buy	1,595 +1,589	+26,483%	+$14.3K	﹤0.01%	8229
2025 Q4	$70	Buy	6 +2	+50%	+$39	﹤0.01%	10234
2025 Q3	$85	Sell	4 -208	-98%	-$5.44K	﹤0.01%	9948
2025 Q2	$7K	Sell	212 -547	-72%	-$19.6K	﹤0.01%	9045
2025 Q1	$27.9K	Sell	759 -1,169	-61%	-$64.6K	﹤0.01%	7997
2024 Q4	$152K	Buy	1,928 +1,894	+5,571%	+$335K	﹤0.01%	6620
2024 Q3	$8.52K	Sell	34 -3	-8%	-$1.01K	﹤0.01%	7835
2024 Q2	$14.8K	Buy	+37	New	+$36.6K	﹤0.01%	7497

Other funds holding AMIX

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

Networth Advisors Canonsburg, Pennsylvania $172M AUM

UBS Group's AMIX Position: Q2 2026 in Review

UBS Group sold out of Autonomix Medical (AMIX) in Q2 2026, closing a stake of 1,595 shares — an estimated $13.1K sold.

UBS Group first reported a position in AMIX in Q2 2024 and held it in 8 quarters. The position peaked at $152K in Q4 2024. 6 funds tracked by Wall St. Rank hold AMIX as of Q2 2026.

UBS Group reported no remaining Autonomix Medical position as of Q2 2026 after selling out during the quarter.
UBS Group sold 1,595 Autonomix Medical shares in Q2 2026, an estimated $13.1K.
UBS Group first reported a position in Autonomix Medical in Q2 2024 and held it in 8 quarters.
UBS Group's Autonomix Medical position peaked at $152K in Q4 2024.
6 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.